Lorcaserin is a medication used as an appetite suppressant to treat obesity. It is marketed under the trade name Belviq. It is believed to work by activating serotonin receptors in the brain which helps to reduce food cravings and promote a feeling of fullness. Lorcaserin is typically taken once a day and should be used along with a healthy diet and regular exercise program. The most common side effects of lorcaserin include headache, dizziness, nausea, and constipation.
Lorcaserin, previously sold under the brand name Belviq, was a prescription medication used for weight loss. It was withdrawn from the market in the United States in 2020 due to an increased risk of cancer in users [1].
Lorcaserin worked by activating a specific type of serotonin receptor in the brain, which helped people feel full and eat less [1]. It was intended to be used along with a reduced-calorie diet and exercise program for chronic weight management in adults with a body mass index (BMI) of 30 or greater (obese) or adults with a BMI of 27 or greater (overweight) with at least one weight-related health problem, such as type 2 diabetes or high blood pressure [2].